Jun. 26 at 7:17 PM
5 longs I have conviction in now and why:
Not posting this at ATHs like most do. Make of that what you will.
$AAOI
Even applying a heavy discount to management’s 2028 assumptions, it still trades around ~2.6x 2028 sales on a steep revenue ramp. Risk is execution, not narrative.
$LLY
Eli Lilly’s GLP-1 + broader drug pipeline dominance could make a
$1T valuation reasonable over a 5-year horizon if execution continues.
$OUST
A “physical AI” infrastructure angle. If lidar adoption expands across robotics and autonomy, TAM expansion is the key driver.
$LMND
Long-term holding through volatility. The thesis is improving unit economics and sustained growth trajectory over time.
$TMQ
Higher-risk copper exposure, paired with COPX as a more diversified play on the same macro theme.
Overall focus is a mix of structural growth, AI-adjacent infrastructure, healthcare innovation, and select commodity exposure.
I often get asked why I don’t turn this into paid content, but for me, sharing stock information is just a hobby. I’m not financially struggling, so I choose to share it for free.
